Xuejie Jiang

Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i> -Mutant Acute Myeloid Leukemia

Xuejie Jiang, Po Yee Mak, Hong Mu et al. · Clinical Cancer Research · 2018 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells

Xiaodong Li, Fang Chen, Qiuhua Zhu et al. · Oncotarget · 2016 · 72 citations · Full text

Medicine, Cell Biology, Oncology +16

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Hua Jin, Yu Zhang, Sijian Yu et al. · Journal of Hematology & Oncology · 2023 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Immunophenotypes and Immune Markers Associated with Acute Promyelocytic Leukemia Prognosis

Fang Xu, Changxin Yin, Chunli Wang et al. · Disease Markers · 2014 · 42 citations · Full text

Medicine, Hematology, Oncology +14

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia

Xuejie Jiang, Ling Jiang, Jiaying Cheng et al. · Journal of Translational Medicine · 2021 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17